1. Sinaei R, Pezeshki S, Parvaresh S, Sinaei R. Why COVID-19
is less frequent and severe in children: a narrative review.
World J Pediatr. 2021;17(1):10-20. doi: 10.1007/s12519-
020-00392-y.
2. Sinaei R, Hosseininasab A, Jafari M, Eslami S, Parvaresh
S. The Multisystem Inflammatory Syndrome of Childhood
(MIS-C). Indian J Pediatr. 2021;88(5):484. doi: 10.1007/
s12098-020-03617-0.
3. Sinaei R, Pezeshki S, Parvaresh S, Sinaei R, Shiari R, Hassas
Yeganeh M, et al. Post SARS-CoV-2 infection reactive arthritis:
a brief report of two pediatric cases. Pediatr Rheumatol
Online J. 2021;19(1):89. doi: 10.1186/s12969-021-00555-9.
4. Clancy CJ, Schwartz IS, Kula B, Nguyen MH. Bacterial
superinfections among persons with coronavirus disease
2019: a comprehensive review of data from postmortem
studies. Open Forum Infect Dis. 2021;8(3):ofab065. doi:
10.1093/ofid/ofab065.
5. Musuuza JS, Watson L, Parmasad V, Putman-Buehler N,
Christensen L, Safdar N. Prevalence and outcomes of coinfection
and superinfection with SARS-CoV-2 and other
pathogens: a systematic review and meta-analysis. PLoS One.
2021;16(5):e0251170. doi: 10.1371/journal.pone.0251170.
6. Venturini E, Montagnani C, Garazzino S, Donà D, Pierantoni
L, Lo Vecchio A, et al. Treatment of children with COVID-19:
position paper of the Italian Society of Pediatric Infectious
Disease. Ital J Pediatr. 2020;46(1):139. doi: 10.1186/s13052-
020-00900-w.
7. Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde
P, Garcia-Pouton N, Chumbita M, et al. Incidence of coinfections
and superinfections in hospitalized patients with
COVID-19: a retrospective cohort study. Clin Microbiol
Infect. 2021;27(1):83-8. doi: 10.1016/j.cmi.2020.07.041.
8. Cawcutt K, Kalil AC. Pneumonia with bacterial and viral
coinfection. Curr Opin Crit Care. 2017;23(5):385-90. doi:
10.1097/mcc.0000000000000435.
9. Hendaus MA, Jomha FA. COVID-19 induced superimposed
bacterial infection. J Biomol Struct Dyn. 2021;39(11):4185-
91. doi: 10.1080/07391102.2020.1772110.
10. Nag VL, Kaur N. Superinfections in COVID-19 patients: role
of antimicrobials. Dubai Med J. 2021;4(2):117-26.
11. Bhat N, Wright JG, Broder KR, Murray EL, Greenberg
ME, Glover MJ, et al. Influenza-associated deaths among
children in the United States, 2003-2004. N Engl J Med.
2005;353(24):2559-67. doi: 10.1056/NEJMoa051721.
12. Randolph AG, Vaughn F, Sullivan R, Rubinson L, Thompson
BT, Yoon G, et al. Critically ill children during the 2009-
2010 influenza pandemic in the United States. Pediatrics.
2011;128(6):e1450-8. doi: 10.1542/peds.2011-0774.
13. Spoto S, Valeriani E, Riva E, De Cesaris M, Tonini G,
Vincenzi B, et al. A Staphylococcus aureus coinfection on a
COVID-19 pneumonia in a breast cancer patient. Int J Gen
Med. 2020;13:729-33. doi: 10.2147/ijgm.s261760.
14. Wang J, Tang Y, Ma Y, Zhou Q, Li W, Baskota M, et al.
Efficacy and safety of antibiotic agents in children with
COVID-19: a rapid review. Ann Transl Med. 2020;8(10):619.
doi: 10.21037/atm-20-3300.
15. Bitar C, Chan MP, Harms PW, Fullen DR, Gudjonsson JE,
Eshaq M, et al. Cutaneous manifestations of hospitalized
coronavirus disease 2019 patients: a report of six cases with
clinicopathologic features and viral RNA in situ hybridization.
J Eur Acad Dermatol Venereol. 2020;34(11):e656-e9. doi:
10.1111/jdv.16741.
16. Khalili M, Iranmanesh B, Mohammadi S, Aflatoonian M.
Cutaneous and histopathological features of coronavirus
disease 2019 in pediatrics: a review article. Dermatol Ther.
2021;34(1):e14554. doi: 10.1111/dth.14554.